This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidemiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The incidence of congenital CMV is 0.3% - 0.4% in the U.K. Approximately 30 to 50% of these cases are due to a reactivation of the virus (1)

About 1% of all seropositive mothers transmit the infection to the fetus (1)

A review states that:

  • congenital cytomegalovirus (cCMV) is common, occurring in one in every 100-200 live births globally (2)

Primary versus non-primary CMV infection (2)

  • primary infections
    • occur when CMV is contracted for the first time just before or during pregnancy, posing a 30-35% risk of fetal transmission
  • non-primary infections
    • occur when the childbearing parent has pre-existing CMV immunity but is exposed to a different strain, or has a reactivation of a latent infection
    • risk for fetal transmission is lower (approximately 1%) with non-primary infections
  • primary infections (versus non-primary) and those that occur earlier (versus later) in gestation are associated with poorer fetal outcomes

Reference:

  • Paryani et al (1985), Journal of Pediatrics, 107, 451
  • Pesch MH et al. Congenital cytomegalovirus infection.BMJ 2021;373:n1212 | doi: 10.1136/bmj.n1212.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.